Top Stories
-
Explore pioneering work in AI, cell therapy and immunotherapy, and our approach to compassionate, community-informed care in the 2024 Pathways to a Cure annual report.
Topic
-
A Columbia clinical trial led by Hua-Jay Cherng, MD, will partner with Foresight Diagnostics to evaluate more personalized cancer treatments for patients with diffuse large B-cell lymphoma (DLBCL)..
Topic
-
Columbia physician-scientist Ryan Moy, MD, PhD, is pioneering research in gastric cancer, including a promising new clinical trial using pill-based therapies to treat diffuse gastric cancer.
Topic
-
Study led by Melissa Beauchemin, PhD, highlights that inadequate translation and interpretation services in the U.S. contributes to lack of representation in cancer clinical trials.
Topic
Latest News
- June 5, 2021
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
- May 20, 2021
A novel drug combination is showing early promise for an entirely new, bladder-saving treatment option for patients.
- November 13, 2020
November marks Pancreatic Cancer Awareness month, and in this in-depth Q+A, Dr. Gulam Manji takes us through the exciting advances in pancreatic cancer treatment and research.
Topic
- May 4, 2020
Dr. Matthew Dallos and colleagues have opened the first clinical trial testing an anti-IL-8 compound as a potential therapy against COVID-19.
Topic
- February 24, 2020
A new clinical trial for AL amyloidosis is paving the way for a promising new treatment option for patients with the rare organ-debilitating disease.
Topic
